Close Menu
    What's Hot

    Longevity & Mortality Investor Conference 2026

    May 19, 2026

    Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    May 18, 2026

    International Life Settlement Forum 2026

    May 18, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      May 18, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026
      Just Group

      Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

      May 11, 2026

      Bakkavor Pension Scheme Completes Bulk Purchase Annuity Buy-In With Rothesay

      May 5, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      LISA Files Amicus Brief Highlighting Consumer Impact of Adverse Ruling Regarding Term Life Insurance Policies

      May 18, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026

      UK Equity Release Market Origination Slows To Begin 2026

      May 6, 2026

      Longevity & Mortality Investor Conference 2026

      May 19, 2026

      Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      May 18, 2026

      International Life Settlement Forum 2026

      May 18, 2026

      LISA Files Amicus Brief Highlighting Consumer Impact of Adverse Ruling Regarding Term Life Insurance Policies

      May 18, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Private Equity’s Reshaping of the Asian Life Sector Has Further To Run

    Life Insurance October 9, 2024By Matthew Rose and Victor Hai
    Share
    Twitter LinkedIn Email

    Private equity-backed reinsurers’ appetite for Asian life insurance assets is unlikely to be sated any time soon, as there is $2 trillion of assets/liabilities under management that are currently providing sub-par capital returns. Shareholder pressure and new capital standards are likely to drive companies in Japan to move first.

    As of December 31, 2023, private equity-backed reinsurance transactions representing $25 billion of assets had occurred in Asia, only 2 percent of the addressable total. However, the value of deals rose tenfold between 2019 and 2023, led by recent transactions between insurers such as AXA HK, Manulife, FWD, T&D, Daiichi and Japan Post and reinsurers such as KKR-backed Global Atlantic, Apollo-backed Athene, Blackstone-backed Resolution, Carlyle-backed Fortitude and Reinsurance Group of America (RGA).

    The influx of private equity money delivers considerable benefits to the Asian life sector, which is experiencing an unprecedented wave of regulatory change, as well as grappling with the introduction of International Financial Reporting Standard 17 (IFRS-17). New regulatory regimes are being introduced across the region to make them more focused on risk-based capital frameworks, with changes already in place in Australia, Mainland China, South Korea, Hong Kong and Singapore, and due to come into effect in Japan and Taiwan.

    These reforms are leading life insurers to de-risk their balance sheets and seek to exit longer-term, or more capital-intensive, liabilities. Through entering these transactions, insurers are able to free up capital they can then use either to improve their solvency ratio or reinvest in areas such as digitisation or new, more-profitable products.

    Concurrently, just as private equity firms are becoming more bullish on the life insurance sector, Asian insurers have become increasingly bullish on investing in private equity and private credit, with the Asian trend toward investing in these areas outpacing the change in EMEA and the US.1

    For private equity-backed reinsurers, the transactions deliver access to in-force books of business that provide permanent capital, which can be re-invested. In addition, through buying up insurance assets in different markets, private equity-backed reinsurers benefit from greater diversification.

    While private equity investment in reinsurance may be relatively new to Asia, it is well established in such regions as the US, where private equity interest in life insurance began with Berkshire Hathaway’s acquisition of National Indemnity in 1967. This interest accelerated after the 2008 financial crisis. At the end of 2022, private equity firms owned 137 US insurance companies with USD 533.7 billion in assets, representing 6.5% of total US insurance assets, according to data from the National Association of Insurance Commissioners.2

    The involvement of private equity firms globally has been met with increased scrutiny from some regulators, with a US Treasury Department Panel and the International Monetary Fund both raising concerns about systemic risks to the economy. This has been caused at least in part by issues raised by some smaller deals in Europe that failed, putting policyholders’ funds at risk.

    However, these unsuccessful transactions represent a small fraction of the overall trend. The majority of insurers continue to see private equity-backed reinsurance as a vital source of capital, with their funds collateralised and quarantined from other assets within substantial, well-funded reinsurers financed by credible global firms.

    In the vast majority of cases, customers experience no change, which is vital for a sector renowned for longevity and stability.

    In the vast majority of cases, customers experience no change, which is vital for a sector renowned for longevity and stability. The carrier retains servicing and administration of the policies. Ultimately, consumers stand to benefit, as the insurers—with newly bolstered balance sheets—redeploy the proceeds into new initiatives and products that enhance the customer experience. This also gives the carrier greater stability to pay any benefits that are non-guaranteed, such as dividends and bonuses, which provides additional certainty that customers receive the product that they have purchased.

    In addition, these private equity-backed reinsurers are carefully monitored both by Asian regulators and at home. Almost all of these acquiring groups are domiciled in Bermuda, which received Solvency II equivalence from the European Commission in 2016, putting the regulatory regime on a par with those in countries such as the US and Canada,3 and where the Bermuda Monetary Authority has continued to make changes to tighten its already conservative and effective supervisory regime.

    The private equity-backed reinsurers provide access to asset classes and investment expertise that often don’t exist within the traditional carriers themselves.

    As with traditional reinsurers, all elements of the reinsurance structure are negotiated, analysed, tested and transparent. In line with an insurer’s appetite for volatility and risk, the reinsurer will find the appropriate balance of asset classes to invest in, and the private equity-backed reinsurers provide access to asset classes and investment expertise that often don’t exist within the traditional carriers themselves.

    Private equity interest in Asia’s life insurance sector is likely to remain strong over the next decade, which will be welcomed by the region’s carriers as they look to satisfy the dual demands of increased capital requirements and enhanced profitability.

    While the recent uptick in transactions has managed to grab the headlines, this may just be the tip of the iceberg. Ultimately, this new injection of funds can only be beneficial for the long-term health of the sector overall.

    Matthew Rose is Managing Director, Practice Leader Life & Health, Asia Pacific and Victor Hai is Senior Vice President, Life & Health, Asia Pacific at Guy Carpenter 


    1. 2024 Global Insurance Survey by Goldman Sachs Asset Management, quoted in Asia Investor.  https://asianinvestor.net/article/asian-insurers-plan-to-add-duration-credit-risk/495380
    2. Insurance Newsnet article, January 9, 2024.  https://insurancenewsnet.com/innarticle/private-equity-stake-in-life-insurers-draws-new-round-of-critical-reports
    3. KPMG report into Life/Long-Term Structures in Bermuda.  https://assets.kpmg.com/content/dam/kpmg/bm/pdf/2021/04/kpmg-life-industry-bermuda-web.pdf

    This Guy Carpenter article originally appeared on guycarp.com

    Any views expressed in this article are those of the author(s) and may not necessarily represent those of Life Risk News or its publisher, the European Life Settlement Association

    2024 - October Alternative Credit Alternative Risk Transfer Commentary Longevity Risk Mortality Risk Volume 3 Issue 10 - October 2024
    Share. Twitter LinkedIn Email

    Related Posts

    Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    May 18, 2026By LMI Newsdesk

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026By Greg Winterton

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble
    Just Group

    Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

    May 11, 2026By LMI Newsdesk
    Latest Issue

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.